Pharmacokinetics of Two Randomized Trials Evaluating the Safety and Efficacy of Indinavir, Saquinavir and Lopinavir in Combination with Low-Dose Ritonavir: The MaxCmin1 and 2 Trials
- 1 November 2007
- journal article
- research article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 101 (5) , 339-344
- https://doi.org/10.1111/j.1742-7843.2007.00117.x
Abstract
SCOPUS: ar.jFLWINinfo:eu-repo/semantics/publisheKeywords
This publication has 21 references indexed in Scilit:
- An Update on Therapeutic Drug Monitoring for Antiretroviral DrugsTherapeutic Drug Monitoring, 2006
- Randomized Trial to Evaluate Indinavir/Ritonavir versus Saquinavir/Ritonavir in Human Immunodeficiency Virus Type 1–Infected Patients: The MaxCmin1 TrialThe Journal of Infectious Diseases, 2003
- Toxicity of antiretroviral therapy and implications for drug developmentNature Reviews Drug Discovery, 2003
- Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individualsAIDS, 2003
- Pharmacokinetics and pharmacodynamics of indinavir with or without low-dose ritonavir in HIV-infected Thai patientsJournal of Antimicrobial Chemotherapy, 2003
- PharmAdaptAIDS, 2002
- Lopinavir–Ritonavir versus Nelfinavir for the Initial Treatment of HIV InfectionNew England Journal of Medicine, 2002
- International Interlaboratory Quality Control Program for Measurement of Antiretroviral Drugs in PlasmaAntimicrobial Agents and Chemotherapy, 2002
- Saquinavir Soft Gelatin CapsuleDrug Safety, 2001
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997